NGM Biopharmaceuticals, Inc. engages in the discovery and development of therapeutics for major diseases with an initial focus on cardio-metabolic and liver diseases. Its portfolio if composed of product candidates which focuses on non-alcoholic steatohepatitis, type 2 diabetes, obesity, oncology and age-related macular degeneration. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.
![Northern Gold Mining logo](/files/LOGO/1497625-NGM.png)
Company profile
Website
CEO
David J. Woodhouse
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Latest filings (excl ownership)
Latest ownership filings
No filings